E

EnLiven Therapeutics

33 employees

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Small Molecule Targeted Therapies
Therapeutics
Oncology
Life Science
Precision Medicine

Date founded

2019

Funding rounds raised

Total raised

$85M

from 6 investors over 6 rounds

E

EnLiven Therapeutics raised $85M on January 19, 2022

Investors: Logos Global Management, LP and Surveyor Capital

E

EnLiven Therapeutics raised $55M on December 7, 2020

Investors: OrbiMed Advisors and 5AM Ventures

E

EnLiven Therapeutics raised undisclosed on January 1, 2019

Investors: OrbiMed Advisors and 5AM Ventures

FAQ